Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wei-Wu Chen

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2026
Across borders and histologies: Rethinking endpoints for vascular sarcoma trialsTom Wei-Wu Chen
Current Treatment Options in Oncology|March 8, 2025
Angiosarcoma: Role of ImmunotherapyTom Wei-Wu Chen
Hu Li Za Zhi the Journal of Nursing|May 24, 2018
[Managing the Adverse Effects Related to Immune Checkpoint Inhibitors]Hsiao-Hsuan Kuo, Wei-Wu Chen
Hu Li Za Zhi the Journal of Nursing|October 5, 2016
[New Hope for HER2-Positive Metastatic Breast Cancer Treatment: Trastuzumab Emtansine (T-DM1) From the Perspective of Nursing Care]Hsiao-Hsuan Kuo, Wei-Wu Chen
ESMO Open|March 6, 2020
Genomic-guided precision therapy for soft tissue sarcomaHsing-Wu Chen, Tom Wei-Wu Chen
Current Opinion in Oncology|October 8, 2013
Personalized medicine for metastatic breast cancerTom Wei-Wu Chen, Philippe L Bedard
Chinese Clinical Oncology|September 4, 2018
Next frontiers in systemic therapy for soft tissue sarcomaCheuh-Chuan Yen, Tom Wei-Wu Chen
Current Opinion in Oncology|May 24, 2023
New targeted treatments for advanced sarcomasChia-Chen Li, Tom Wei-Wu Chen
Current Opinion in Oncology|May 10, 2024
Sarcoma incidence worldwide: regional differences in histology and molecular subtypesMing-Jing Lee, Tom Wei-Wu Chen
World Journal of Clinical Oncology|February 25, 2025
Denosumab combined with immunotherapy, radiotherapy, and granulocyte-macrophage colony-stimulating factor for the treatment of metastatic nasopharyngeal carcinoma: A case reportWei-Wu Chen, Yue-Hong Kong, Li-Yuan Zhang
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 19, 2026
Across borders and histologies: Rethinking endpoints for vascular sarcoma trialsTom Wei-Wu Chen
Current Treatment Options in Oncology|March 8, 2025
Angiosarcoma: Role of ImmunotherapyTom Wei-Wu Chen
Hu Li Za Zhi the Journal of Nursing|May 24, 2018
[Managing the Adverse Effects Related to Immune Checkpoint Inhibitors]Hsiao-Hsuan Kuo, Wei-Wu Chen
Hu Li Za Zhi the Journal of Nursing|October 5, 2016
[New Hope for HER2-Positive Metastatic Breast Cancer Treatment: Trastuzumab Emtansine (T-DM1) From the Perspective of Nursing Care]Hsiao-Hsuan Kuo, Wei-Wu Chen
ESMO Open|March 6, 2020
Genomic-guided precision therapy for soft tissue sarcomaHsing-Wu Chen, Tom Wei-Wu Chen
Current Opinion in Oncology|October 8, 2013
Personalized medicine for metastatic breast cancerTom Wei-Wu Chen, Philippe L Bedard
Chinese Clinical Oncology|September 4, 2018
Next frontiers in systemic therapy for soft tissue sarcomaCheuh-Chuan Yen, Tom Wei-Wu Chen
Current Opinion in Oncology|May 24, 2023
New targeted treatments for advanced sarcomasChia-Chen Li, Tom Wei-Wu Chen
Current Opinion in Oncology|May 10, 2024
Sarcoma incidence worldwide: regional differences in histology and molecular subtypesMing-Jing Lee, Tom Wei-Wu Chen
World Journal of Clinical Oncology|February 25, 2025
Denosumab combined with immunotherapy, radiotherapy, and granulocyte-macrophage colony-stimulating factor for the treatment of metastatic nasopharyngeal carcinoma: A case reportWei-Wu Chen, Yue-Hong Kong, Li-Yuan Zhang
Pageof 8